In this issue:
Regional variations in HCC incidence, diagnosis, treatment and survival in England
Adherence to healthy lifestyle and liver cancer
Long-term survival and complications of pre-liver transplant TACE in HCC
Guided self-help mindfulness-based intervention for HCC
Global burden of primary liver cancer by aetiology
Association between ultrasound quality and test performance for HCC surveillance in cirrhosis
Atezolizumab + bevacizumab vs. sorafenib for unresectable HCC
Liver cancer risk after HCV cure in advanced liver disease patients
LRP1B: a biomarker in HCC patients receiving immune checkpoint inhibitors?
Gemcitabine/cisplatin + durvalumab ±tremelimumab in advanced biliary tract cancer
Please login below to download this issue (PDF)